.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Fabiana Ursitti

Vortrag

08.12.2022
16:00 – 16:05 3 Min. 2 Min.
ePoster
P49
Use of anti-CGRP monoclonal antibodies in pediatric migraine: first evaluations of a phase 3, randomized, double-blind, placebo-controlled study
CGRP inhibitors in the clinic, Headache in children and adolescents

Weitere Beteiligungen

08.12.2022
16:00 – 16:05 3 Min. 2 Min.
ePoster
P49
Use of anti-CGRP monoclonal antibodies in pediatric migraine: first evaluations of a phase 3, randomized, double-blind, placebo-controlled study
CGRP inhibitors in the clinic, Headache in children and adolescents
09.12.2022
15:35 – 15:40 3 Min. 2 Min.
ePoster
P227
Sleep Disorders in Pediatric Migraine: a questionnaire-based study
Headache in children and adolescents , Migraine
09.12.2022
15:40 – 15:45 3 Min. 2 Min.
ePoster
P228
Interictal cognitive performance in children and adolescents with primary headache: a narrative review
Headache in children and adolescents
09.12.2022
15:55 – 16:00 3 Min. 2 Min.
ePoster
P232
Long-term effects of pandemic of Covid-19 on clinical features and psychological symptoms in adolescents with migraine
Headache in children and adolescents , Migraine
09.12.2022
16:00 – 16:05 3 Min. 2 Min.
ePoster
P233
From the new diagnostic criteria to Covid-19 pandemic passing throught the placebo effect. What have we learned in the management of pediatric migraine over the past 5 years? The opinion of Italian pediatric headache centers
Headache in children and adolescents
09.12.2022
16:25 – 16:30 3 Min. 2 Min.
ePoster
P238
Does symptomatic treatment help children and adolescents with chronic migraine?
Headache in children and adolescents , Migraine
09.12.2022
16:30 – 16:35 3 Min. 2 Min.
ePoster
P239
Angelman syndrome and cyclic vomiting syndrome: a new potential association – Not all the vomiting are only vomiting!
Headache in children and adolescents , Migraine